{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:07:04Z","timestamp":1772093224260,"version":"3.50.1"},"reference-count":9,"publisher":"IEEE","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"DOI":"10.1109\/ccwc67433.2026.11393870","type":"proceedings-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:53:57Z","timestamp":1772052837000},"page":"0458-0461","source":"Crossref","is-referenced-by-count":0,"title":["Regression-Based Modeling of Antisense Oligonucleotide Efficacy Using Sequence, Structural, and Off-Target Features"],"prefix":"10.1109","author":[{"given":"Ava","family":"George","sequence":"first","affiliation":[{"name":"Fullerton College,Computer Science,Fullerton,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Bai","sequence":"additional","affiliation":[{"name":"California State University, Fullerton,Computer Engineering,Fullerton,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Tang","sequence":"additional","affiliation":[{"name":"California State University, Fullerton,Computer Engineering,Fullerton,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"263","reference":[{"key":"ref1","first-page":"419","article-title":"Antisense drug discovery and development","volume":"16","author":"Crooke","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref2","first-page":"829","article-title":"The therapeutic potential of steric blocking oligonucleotides","volume":"12","author":"Crooke","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Wakap","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"ref4","first-page":"e15974","article-title":"Artificial intelligence for rare disease therapy development","volume":"35","author":"Bishop","year":"2021","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"ref5","first-page":"1","article-title":"The chemical evolution of antisense therapeutics","volume":"7","author":"Khvorova","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"I414658","DOI":"10.3389\/fnins.2024.1414658","article-title":"Antisense oligonucleotides and their applications in rare neurological diseases","volume":"18","author":"McDowall","year":"2024","journal-title":"Front. Neurosci."},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-023-00419-1","article-title":"Possibilities and limitations of antisense oligonucleotide therapies for monogenic disorders","volume":"4","author":"Lauffer","year":"2024","journal-title":"Commun. Med."},{"key":"ref8","volume-title":"ASOptimizer dataset repository","year":"2024"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102186","article-title":"ASOptimizer: Optimizing antisense oligonucleotides through deep learning for IDO1 gene regulation","volume-title":"Mol. Ther. Nucleic Acids","author":"Hwang","year":"2024"}],"event":{"name":"2026 IEEE 16th Annual Computing and Communication Workshop and Conference (CCWC)","location":"Las Vegas, NV, USA","start":{"date-parts":[[2026,1,5]]},"end":{"date-parts":[[2026,1,7]]}},"container-title":["2026 IEEE 16th Annual Computing and Communication Workshop and Conference (CCWC)"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx8\/11393680\/11393642\/11393870.pdf?arnumber=11393870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:10:17Z","timestamp":1772089817000},"score":1,"resource":{"primary":{"URL":"https:\/\/ieeexplore.ieee.org\/document\/11393870\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1109\/ccwc67433.2026.11393870","relation":{},"subject":[],"published":{"date-parts":[[2026,1,5]]}}}